OCT 16, 2018 10:37 PM PDT

Anti-Venomous Plant Compound

WRITTEN BY: Nouran Amin

According to a study published in PLOS Neglected Tropical Diseases, researchers at the Institute Butantan, São Paulo, Brazil, have discovered a flavonoid found in plants to be effective in acting as antivenom compound from the South American pit viper Bothrops jaraca.

The viper is most commonly found northern Argentina, southern Brazil and northeastern Paraguay. It is an abundant species and the large cause of snakebites. Their venom is composed of a mixture of complex proteins that disrupt chemical reactions inside cells.

Being bitten by the snake, can lead to site swelling, blistering, severe hypotension and systemic bleeding from the skin, nose, and gums--eventually leading to shock, intracranial hemorrhage, or renal failure. More than often, the venom of the viper causes proteolytic, coagulant and hemorrhagic effects. Uniquely, these properties are based on a peptide found in their venom which is presently being used for drug development in the treatment of heart failure and hypertension.

Image via RisingKashmir.com

The flavonoid identified is called ‘rutin’ which can protect envenomed mice from bleeding and inflammation complications. Current anti-venoms can treat the major issues arising from a snake bite however, it cannot treat common saucer implications of the bite including bleeding.

Chemical Structure of Rutin. Image via 'Rutin' from Wikipedia

Existing anti-venoms can treat the major effects of the snake bites however, there are no known therapies for common secondary complications, such as the inability to stop the bleeding.

Results of the research were derived from studies on mouse models injected with both venom and rutin. The mice were than further analyzed for the physiological triggers of venom to better understand the effects rutin on pathophysiological events triggered by the venom. The research findings ‘indicates that rutin has a great potential as an ancillary drug in concert with antivenom therapy to treat snakebites, particularly in countries where antivenom availability is scarce.’

 

Source: Drug Target Review

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 11, 2018
Microbiology
JUL 11, 2018
New Insight Into Bacterial Pathogenicity
Scientists have learned how some pathogenic bacteria stick to cells in the intestine, which gets their infection started....
AUG 08, 2018
Drug Discovery
AUG 08, 2018
Cholesterol Pill For Treating A Brutal Lung Disease
A brutal lung disease called Pulmonary Alveolar Proteinosis (PAP) is caused by a thick substance known as surfactant that clogs up the air sacs in the lung...
AUG 14, 2018
Cancer
AUG 14, 2018
New Drug for Refractory Cutaneous T-cell Lymphoma
Mogamulizumab was approved by the FDA this month after a very successful Phase III clinical trial demonstrating its effectiveness in treating patients with challenging CTCL....
AUG 15, 2018
Drug Discovery
AUG 15, 2018
Experimental Drug May Treat The Chronic Itch
Investigators at the University of Zurich have discovered a new approach that treats the chronic itch thanks to two receptors in the spinal cord and the ri...
SEP 24, 2018
Drug Discovery
SEP 24, 2018
Protein Serves as a Potential Drug Target
Researchers at Van Andel Research Institute (VARI) have shown an atomic-level structure of a protein that may serve as a future drug target for conditions ...
OCT 02, 2018
Cell & Molecular Biology
OCT 02, 2018
Approved Drug may Slow the Progression of Alzheimer's
For many, Alzheimer's disease is just a fact of old age; around 50 percent of people that live to age 85 will get the disorder....
Loading Comments...